Cancer Research UK logo.
SearchDonate
  • Search

A trial of cabazitaxel for liposarcoma (EORTC-1202)

Overview

Cancer types:

Sarcoma, Secondary cancers, Soft tissue sarcoma

Status:

Results

Phase:

Phase 2

Details

This trial looked at cabazitaxel for liposarcoma that had spread to other parts of the body. Or it wasn’t possible to remove the sarcoma with surgery. This is advanced liposarcoma.

The trial was open for people to join between 2017 and 2019. The team presented the results at a conference in 2020.

Recruitment start: 1 March 2015

Recruitment end: 31 March 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Richard L Hayward

Supported by

European Organisation for Research and Treatment of Cancer (EORTC)

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Sanofi

Last reviewed: 11 October 2022

CRUK internal database number: 12333

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.